BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30514976)

  • 21. FGF23 and mineral metabolism, implications in CKD-MBD.
    Rodríguez M; López I; Muñoz J; Aguilera-Tejero E; Almaden Y
    Nefrologia; 2012 May; 32(3):275-8. PubMed ID: 22592418
    [No Abstract]   [Full Text] [Related]  

  • 22. Phosphate-sensing and regulatory mechanism of FGF23 production.
    Takashi Y; Fukumoto S
    J Endocrinol Invest; 2020 Jul; 43(7):877-883. PubMed ID: 32140858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Chronic kidney disease (CKD) and bone. Regulation of calcium and phosphate metabolism by FGF23/Klotho].
    Fukumoto S
    Clin Calcium; 2009 Apr; 19(4):523-8. PubMed ID: 19329831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-23 (FGF23) in patients with transient hypoparathyroidism: its important role in serum phosphate regulation.
    Yamashita H; Yamazaki Y; Hasegawa H; Yamashita T; Fukumoto S; Shigematsu T; Kazama JJ; Fukagawa M; Noguchi S
    Endocr J; 2007 Jun; 54(3):465-70. PubMed ID: 17464094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study.
    Fliser D; Kollerits B; Neyer U; Ankerst DP; Lhotta K; Lingenhel A; Ritz E; Kronenberg F; ; Kuen E; König P; Kraatz G; Mann JF; Müller GA; Köhler H; Riegler P
    J Am Soc Nephrol; 2007 Sep; 18(9):2600-8. PubMed ID: 17656479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGF23-parathyroid interaction: implications in chronic kidney disease.
    Komaba H; Fukagawa M
    Kidney Int; 2010 Feb; 77(4):292-8. PubMed ID: 20010546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression.
    Meyer MB; Pike JW
    J Steroid Biochem Mol Biol; 2020 Feb; 196():105500. PubMed ID: 31629064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. With or without the kidney: the role of FGF23 in CKD.
    Fukagawa M; Kazama JJ
    Nephrol Dial Transplant; 2005 Jul; 20(7):1295-8. PubMed ID: 15840677
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of an oral sodium phosphate load on parathyroid hormone and fibroblast growth factor 23 secretion in normo- and hypercalciuric stone-forming patients.
    Irzyniec T; Boryń M; Kasztalska J; Nowak-Kapusta Z; Maciejewska-Paszek I; Grochowska-Niedworok E
    Clin Nutr; 2020 Dec; 39(12):3804-3812. PubMed ID: 32386861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease.
    van Husen M; Fischer AK; Lehnhardt A; Klaassen I; Möller K; Müller-Wiefel DE; Kemper MJ
    Kidney Int; 2010 Jul; 78(2):200-6. PubMed ID: 20407479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibroblast growth factor 23 and phosphate homeostasis.
    Balani S; Perwad F
    Curr Opin Nephrol Hypertens; 2019 Sep; 28(5):465-473. PubMed ID: 31335449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hormonal regulation of phosphate balance].
    Tanaka H; Fukagawa M
    Clin Calcium; 2012 Oct; 22(10):1477-85. PubMed ID: 23023626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kidney fibroblast growth factor 23 does not contribute to elevation of its circulating levels in uremia.
    Mace ML; Gravesen E; Nordholm A; Hofman-Bang J; Secher T; Olgaard K; Lewin E
    Kidney Int; 2017 Jul; 92(1):165-178. PubMed ID: 28341272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fibroblast growth factor 23: a new player in the field of cardiovascular, bone and renal disease.
    Cozzolino M; Mazzaferro S
    Curr Vasc Pharmacol; 2010 May; 8(3):404-11. PubMed ID: 20180772
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrarenal effects of FGF23.
    Haffner D; Leifheit-Nestler M
    Pediatr Nephrol; 2017 May; 32(5):753-765. PubMed ID: 27704252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FGF23 beyond Phosphotropic Hormone.
    Takashi Y; Fukumoto S
    Trends Endocrinol Metab; 2018 Nov; 29(11):755-767. PubMed ID: 30217676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD].
    Komaba H
    Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FGF23 in chronic kidney disease.
    Wahl P; Wolf M
    Adv Exp Med Biol; 2012; 728():107-25. PubMed ID: 22396166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3.
    Kägi L; Bettoni C; Pastor-Arroyo EM; Schnitzbauer U; Hernando N; Wagner CA
    PLoS One; 2018; 13(5):e0195427. PubMed ID: 29771914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Klotho gene, phosphocalcic metabolism, and survival in dialysis.
    Torres PU; Prié D; Beck L; De Brauwere D; Leroy C; Friedlander G
    J Ren Nutr; 2009 Jan; 19(1):50-6. PubMed ID: 19121771
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.